glp 1 drugs and ulcerative colitis Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, therapeutic potential Summary of the reviewed studies
Description
Ozempic accounted for 2% of this amount
Neurogastroenterol Motil 2017;29
Metformin works in the liver and helps your body use insulin more efficiently, so its side effects look a bit different
Almost three decades ago, the discovery of leptin triggered a new era of molecular obesity research
The major players are Eli Lilly and Company, Sanofi, Novo Nordisk, AstraZeneca, Boehringer Ingelheim, Amgen, GSK, Pfizer, Hanmi Science
